<DOC>
	<DOC>NCT02817139</DOC>
	<brief_summary>This study is a pilot, double-blind, placebo-controlled, randomized trial aiming to compare the effects of transcranial direct current stimulation in Chronic Migraine.</brief_summary>
	<brief_title>Transcranial Direct Current Simulation in Chronic Migraine</brief_title>
	<detailed_description>The patients will be randomized into 1 of 3 groups: active tDCS over primary motor cortex, active tDCS over prefrontal cortex, sham tDCS. Each group will receive treatment for 20 minutes a day, 3 days a week for 4 weeks.</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>patients with a clinical diagnosis of chronic migraine according to the International Classification of Headaches Disorders (ICHD3 beta) of the International Headache Society, with an established headache history occurring on 15 or more days per monthâ€”however, for at least 1 year, instead of only 3 months, as defined in the International Headache Society (IHS) guidelines. headache attributable to some pathological condition, associated neurologic or neuropsychiatric disease, use of central nervous system modulating drugs, pregnancy, metallic head implants, and use of a cardiac pacemaker.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>